Mycophenolate sodium switch successful in renal transplantation

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1515, 2005-01, pp. : 11-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Switch to mycophenolate sodium for better GI tolerability

Reactions Weekly, Vol. 1, Iss. 1288, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Mycophenolate Sodium Delayed Release: Prevention of Renal Transplant Rejection

By Curran Monique P. Keating Gillian M.

Drugs, Vol. 65, Iss. 6, 2005-01 ,pp. : 799-805

Adis International

Access to resources Recommend Favorite

Population Pharmacokinetics of Mycophenolic Acid: A Comparison between Enteric-Coated Mycophenolate Sodium and Mycophenolate Mofetil in Renal Transplant Recipients

By de Winter Brenda C.M.

Clinical Pharmacokinetics, Vol. 47, Iss. 12, 2008-01 ,pp. : 827-838

Adis International

Access to resources Recommend Favorite

Switching from azathioprine to mycophenolate mofetil (MMF) improves renal function in paediatric patients with chronic rejection following renal transplantation

Inpharma, Vol. 1, Iss. 1255, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Safety considerations with mycophenolate sodium

By Filler Guido Buffo Ilan

Expert Opinion on Drug Safety, Vol. 6, Iss. 4, 2007-07 ,pp. : 445-449

Informa Healthcare

Access to resources Recommend Favorite